99% Savings - Buy Just @1 Rs X
Zekacin 250 Mg Injection is a prescription medicine that is available as a Injection. Urinary Tract Infection are some of its major therapeutic uses. The alternative uses of Zekacin 250 Mg Injection have also been explained below.
The correct dosage of Zekacin 250 Mg Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Zekacin 250 Mg Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Zekacin 250 Mg Injection go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Zekacin 250 Mg Injection has a Severe effect for pregnant women and Unknown effect on lactating mothers. Further, the section on Zekacin 250 Mg Injection related warnings talks about Zekacin 250 Mg Injection's effects on the liver, heart and kidney.
Zekacin 250 Mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zekacin 250 Mg Injection in conditions like Dehydration, Parkinson's Disease, Hearing Loss. Some other conditions that can be affected by Zekacin 250 Mg Injection are listed in the contraindications section below.
Drug interactions for Zekacin 250 Mg Injection have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Zekacin 250 Mg Injection is safe while driving, and is is addictive in nature.
Zekacin 250 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Zekacin 250 Mg Injection safe for pregnant women?
Zekacin can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Zekacin 250 Mg Injection safe during breastfeeding?
There is no research available on the side effects of Zekacin in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Zekacin 250 Mg Injection on the Kidneys?
Use of Zekacin may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Zekacin 250 Mg Injection on the Liver?
Zekacin has very mild side effects on the liver.
What is the effect of Zekacin 250 Mg Injection on the Heart?
Side effects of Zekacin rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Zekacin 250 Mg Injection unless your doctor advises you to do so -
Is this Zekacin 250 Mg Injection habit forming or addictive?
No, there is no any evidence that Zekacin 250 Mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Zekacin 250 Mg Injection since it will not make you feel sleepy.
Is it safe?
Zekacin 250 Mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Zekacin 250 Mg Injection cannot treat any kind of mental disorder.
Interaction between Food and Zekacin 250 Mg Injection
It is safe to take Zekacin 250 Mg Injection with food.
Interaction between Alcohol and Zekacin 250 Mg Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Zekacin 250 Mg Injection.
Yes, Zekacin has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
Occasionally, Zekacin can cause drug-induced thrombocytopenia (blood clot formation in the vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Zekacin is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Do not self-administer Zekacin. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking Zekacin please inform your doctor immediately.
Yes, Zekacin is effective against bacteria (Pseudomonas). But it is also found that Pseudomonas can get resistant to this drug and in that case Zekacin will not produce desired results. If you are experiencing no symptomatic relief after taking this medicine then inform your doctor and follow his/her instructions.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137